Back to Screener

Healthcare

Scinai Immunotherapeutics Ltd.(SCNI)

Live Price

Offline

$0.331

+1.85% today

1Y Change

-81.55%

Window

Jun 23, 2025 β†’ Jun 5, 2026

Market Cap
β€”
Revenue Growth
+99.2%
EPS Growth
-160.0%
Dividend Yield
0.0%

Coverage: 240 bars Β· Jun 23, 2025 β†’ Jun 5, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Scinai Immunotherapeutics Ltd. (SCNI) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.33 and down 81.6% across the available one-year price window (Jun 23, 2025 β†’ Jun 5, 2026). Baseline metrics include revenue growth of +99.2%, EPS growth of -160.0%, a dividend yield of 0.0%. What stands out right now is revenue +99.2%, EPS -160.0%, free cash flow +4.6% with operating margin -574.0% and ROIC -72.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SCNI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SCNI

β€”

Normalized return

SPY

β€”

S&P 500

Excess Return

β€”

Relative to SPY

SCNI Max Drawdown

-83.64%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SCNI and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Next earningsJul 7, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
Jul 7, 26
TBD
β€”
Est β€”
β€”
β€”
Est β€”
β€”
Jul 7
β€”
May 7, 26
β€”
Est β€”
β€”
β€”
Est β€”
β€”
May 7
β€”
Dec 2, 25
-1.33
Est β€”
β€”
277.3B
Est β€”
β€”
Dec 2
β€”
Sep 2, 25
-3.57
Est β€”
β€”
115.5B
Est β€”
β€”
Sep 2
β€”
May 30, 25
-0.00
Est β€”
β€”
158.0B
Est β€”
β€”
May 30
β€”
May 7, 25
-10.40
Est β€”
β€”
56.5B
Est β€”
β€”
May 7
β€”
Nov 22, 24
8.40
Est β€”
β€”
44.2B
Est β€”
β€”
Nov 22
β€”
Aug 15, 24
-3.57
Est β€”
β€”
75.4B
Est β€”
β€”
Aug 15
β€”
Jul 2, 24
-4.00
Est β€”
β€”
β€”
Est β€”
β€”
Jul 2
β€”
May 15, 24
βœ—
-240.00
Est -0.62
-38609.7%
β€”
Est β€”
β€”
May 15
β€”
Oct 31, 23
βœ—
-6.60
Est -0.99
-566.7%
β€”
Est β€”
β€”
Oct 31
β€”
Aug 11, 23
βœ—
-1.11
Est -0.91
-22.0%
β€”
Est β€”
β€”
Aug 11
β€”
May 15, 23
βœ“
-1.20
Est -22.00
+94.5%
β€”
Est β€”
β€”
May 15
β€”
Apr 17, 23
-0.30
Est β€”
β€”
β€”
Est β€”
β€”
Apr 17
β€”
Sep 30, 22
βœ“
0.00
Est -1.00
+100.0%
β€”
Est β€”
β€”
Sep 30
β€”
Jun 30, 22
βœ“
-0.00
Est -1.00
+99.9%
β€”
Est β€”
β€”
Jun 30
β€”
Mar 31, 22
-0.00
Est β€”
β€”
β€”
Est β€”
β€”
Mar 31
β€”
Dec 31, 21
0.00
Est β€”
β€”
β€”
Est β€”
β€”
Dec 31
β€”
Sep 30, 21
-0.00
Est β€”
β€”
β€”
Est β€”
β€”
Sep 30
β€”
Jun 30, 21
-0.00
Est β€”
β€”
β€”
Est β€”
β€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener